Francesca Khani

23PUBLICATIONS
205CO-AUTHORS
Predictive and prognostic markersMolecular targetsCell physiologyWomen's studies (incl. girls' studies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 16, 2026
The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer.

|Sep 10, 2026
Integrated signatures define mutational processes in prostate cancer.

|Sep 09, 2026
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.

|May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists.

Mahra Nourbakshs, Liping Du, Andres M Acosta

|Dec 13, 2024
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.

Xuanrong Chen, Michael A Augello, Deli Liu

|Nov 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz

Pageof 4

Frequent Collaborators

12 joint publications

Brian Robinson

6 joint publications

Himisha Beltran

6 joint publications

Olivier Elemento

5 joint publications

Andrea Sboner